Treatment of Chronic Hepatitis C in Canadian Prison Inmates
PURPOSE: To assess sustained viral response rate and adherence to standard interferon alpha-2b and ribavirin therapy in inmates with chronic hepatitis C (HCV) in Canadian penitentiaries in the Pacific region.
Saved in:
Main Authors: | John D Farley, Victor K Wong, Henry V Chung, Elizabeth Lim, Gavin Walters, Theresa A Farley, Eric M Yoshida |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2005-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2005/767540 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk Prison and Hepatitis B Virus Infection among Inmates with History of Drug Injection in Isfahan, Iran
by: Daneshmand Dana, et al.
Published: (2013-01-01) -
The exercise of the right of prison inmates to have contact with their children in the context of contemporary research on childhood
by: Karolina Chorąży, et al.
Published: (2022-12-01) -
An Update on the Management of Chronic Hepatitis C: Consensus Guidelines from the Canadian Association for the Study of the Liver
by: Robert P Myers, et al.
Published: (2012-01-01) -
A Hepatitis C Educational Needs Assessment of Canadian Healthcare Providers
by: Reza Naghdi, et al.
Published: (2017-01-01) -
Prevalence and epidemiological characteristics of inmates diagnosed with infectious diseases living in a region with a high number of prisons in São Paulo state, Brazil
by: Charlene Troiani do Nascimento, et al.
Published: (2020-09-01)